Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir plus hydroxychloroquine versus hydroxychloroquine in hospitalized patients with COVID-19
IRCT20200428047228N1Phase 3Completed
- Sponsor
- Quality Improvement of Intensive Care Research Center
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Favipiravir + hydroxychloroquine with Hydroxychloroquine alone (2 arms). Started May 2020; status: completed.
02
Drugs
favipiravirhydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200428047228N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200428047228N1.